Fennec Pharmaceuticals Inc. (FENC) vs Orchestra BioMed Holdings, Inc. (OBIO)
A side-by-side comparison of Fennec Pharmaceuticals Inc. and Orchestra BioMed Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FENC
Fennec Pharmaceuticals Inc.
$10.20HealthcareDelayed quote: Oct 6, 2026, 1:28 PM EDT
OBIO
Orchestra BioMed Holdings, Inc.
$5.90HealthcareDelayed quote: Oct 6, 2026, 1:29 PM EDT
Total return — FENC vs OBIO
growth of $100 · dividends reinvested · last 6yFENC +25.7% (+3.9%/yr)OBIO -47.1% (-10.1%/yr)FENC compounded faster over this window
FENC OBIO
FENC vs OBIO: by the numbers
- •FENC is the larger company ($354M vs $353M market cap).
- •Both run net losses; FENC's is the smaller (-5.49% vs -184.60% net margin).
- •FENC grew revenue faster over the past five years (222.46% vs 148.45% CAGR).
Metrics side by side
Valuation
| Metric | FENC | OBIO |
|---|---|---|
| Forward P/E | 36.00 | N/A |
| P/S ratio | 5.98 | 11.04 |
| P/B ratio | 8.35 | 18.27 |
Profitability
| Metric | FENC | OBIO |
|---|---|---|
| Gross margin | 93.73% | 99.32% |
| Operating margin | -14.22% | -154.73% |
| Net margin | -5.49% | -184.60% |
| ROE | -7.66% | -200.64% |
| ROIC | -1.84% | -56.73% |
Growth (annualized)
| Metric | FENC | OBIO |
|---|---|---|
| Revenue CAGR (5Y) | 222.46% | 148.45% |
| Total return CAGR (5Y) | 2.45% | -9.35% |
Frequently asked
- Which has grown faster, FENC or OBIO?
- Over the past five years, FENC grew revenue faster — FENC at a 222.46% CAGR versus OBIO at 148.45%.
- How have FENC and OBIO total returns compared?
- Over the past 5 years, FENC delivered 2.45% and OBIO delivered -9.35% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Fennec Pharmaceuticals ROEOrchestra BioMed ROEFennec Pharmaceuticals operating marginOrchestra BioMed operating marginFennec Pharmaceuticals revenue growthOrchestra BioMed revenue growthFennec Pharmaceuticals free cash flowOrchestra BioMed free cash flow
Fennec Pharmaceuticals & Orchestra BioMed appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.